BMND7
MCID: BNM021
MIFTS: 14

Bone Mineral Density Quantitative Trait Locus 7 (BMND7)

Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Bone Mineral Density Quantitative Trait Locus 7

MalaCards integrated aliases for Bone Mineral Density Quantitative Trait Locus 7:

Name: Bone Mineral Density Quantitative Trait Locus 7 58
Bmnd7 58

Classifications:



External Ids:

OMIM 58 611738

Summaries for Bone Mineral Density Quantitative Trait Locus 7

MalaCards based summary : Bone Mineral Density Quantitative Trait Locus 7, also known as bmnd7, is related to osteoporosis. An important gene associated with Bone Mineral Density Quantitative Trait Locus 7 is BMND7 (Bone Mineral Density Quantiative Trait Locus 7). The drugs Norepinephrine and Sertraline have been mentioned in the context of this disorder. Affiliated tissues include bone.

Description from OMIM: 611738

Related Diseases for Bone Mineral Density Quantitative Trait Locus 7

Symptoms & Phenotypes for Bone Mineral Density Quantitative Trait Locus 7

Clinical features from OMIM:

611738

Drugs & Therapeutics for Bone Mineral Density Quantitative Trait Locus 7

Drugs for Bone Mineral Density Quantitative Trait Locus 7 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 22)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Norepinephrine Approved Phase 3 51-41-2 439260
2
Sertraline Approved Phase 3 79617-96-2 68617
3
Reboxetine Approved, Experimental Phase 3 98769-81-4, 71620-89-8 65856 123628
4
Citalopram Approved Phase 3 59729-33-8 2771
5 Parasympatholytics Phase 3
6 Antidepressive Agents Phase 3
7 Neurotransmitter Uptake Inhibitors Phase 3
8 Peripheral Nervous System Agents Phase 3
9 Venlafaxine Hydrochloride Phase 3
10 Antiparkinson Agents Phase 3
11 Cholinergic Agents Phase 3
12 Cholinergic Antagonists Phase 3
13 Antidepressive Agents, Second-Generation Phase 3
14 Autonomic Agents Phase 3
15 Psychotropic Drugs Phase 3
16 Neurotransmitter Agents Phase 3
17 Serotonin Agents Phase 3
18 Serotonin Uptake Inhibitors Phase 3
19 Adrenergic Agents Phase 3
20 Muscarinic Antagonists Phase 3
21 Serotonin and Noradrenaline Reuptake Inhibitors Phase 3
22
Serotonin Investigational, Nutraceutical Phase 3 50-67-9 5202

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Antidepressants and Bone Mineral Density Completed NCT02179268 Phase 3 sertraline;citalopram;venlafaxine;reboxetine

Search NIH Clinical Center for Bone Mineral Density Quantitative Trait Locus 7

Genetic Tests for Bone Mineral Density Quantitative Trait Locus 7

Anatomical Context for Bone Mineral Density Quantitative Trait Locus 7

MalaCards organs/tissues related to Bone Mineral Density Quantitative Trait Locus 7:

42
Bone

Publications for Bone Mineral Density Quantitative Trait Locus 7

Variations for Bone Mineral Density Quantitative Trait Locus 7

Expression for Bone Mineral Density Quantitative Trait Locus 7

Search GEO for disease gene expression data for Bone Mineral Density Quantitative Trait Locus 7.

Pathways for Bone Mineral Density Quantitative Trait Locus 7

GO Terms for Bone Mineral Density Quantitative Trait Locus 7

Sources for Bone Mineral Density Quantitative Trait Locus 7

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....